SYK
Stryker Corporation · Healthcare · Medical - Devices
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -1.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 7 | 0 | 2.75M | $746.85M | n/a | n/a |
| Q2 2026 | 172 | +2 | 222.54M | $70.41B | +7 | −4 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | n/a | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | n/a |
| Q2 2024 | 16 | n/a | 41.27M | $14.03B | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 33.50M | n/a | $13.25B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 26.63M | n/a | $10.53B | 0.2% | n/c | 1 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (被动) | 14.96M | +1.0% | $5.93B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 11.90M | -1.9% | $4.71B | 0.5% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (被动) | 7.39M | +1.1% | $2.91B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 7.15M | n/a | $2.83B | 0.2% | n/c | 1 | SEC ↗ ×7 |
| 7 | Wellington Management ✦ | 5.56M | -13.1% | $2.20B | 0.4% | ▼ Trim | 5 | SEC ↗ ×6 |
| 8 | Norges Bank ✦ (被动) | 4.76M | -6.3% | $1.88B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 3.45M | -5.6% | $1.37B | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 10 | PRIMECAP Management ✦ | 504.76K | +16.1% | $199.70M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 480.54K | +111.1% | $190.12M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 414.91K | -37.6% | $164.15M | 0.2% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | Adage Capital Partners ✦ | 235.48K | +75.3% | $93.16M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 123.39K | +8.4% | $48.59M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 15 | GAMCO Investors ✦ | 22.18K | +2.1% | $8.77M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 12.39K | +35.2% | $4.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 11.87K | -23.4% | $4.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Marshall Wace ✦ | 5.70K | -75.1% | $2.26M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Millennium Management ✦ | 4.37K | -84.4% | $1.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Harris Associates (Oakmark) ✦ | 571 | 新增 | $225,905 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Harris Associates (Oakmark) | $225,905 | 0.0% |
已清仓
| Arrowstreet Capital | $8.74M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 2,274 持有人, 283.44M 股份, $87.41B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Director · 18 股 @ 225.19 · $4,054
Director · 3 股 @ 185.65 · $557
Director · 36 股 @ 193.21 · $6,956
Director · 11 股 @ 221.03 · $2,431
Director · 63 股 @ 202.21 · $12,739
公开市场卖出 (S)
Officer · 441 股 · $144,915
Director · 11.26K 股 · $3.81M
Director · 40 股 · $13,272
Director · 440 股 · $146,598
Director · 200 股 · $66,786
Director · 80 股 · $26,804
Director · 320 股 · $107,774
Director · 2.31K 股 · $780,062
Director · 10.81K 股 · $3.67M
Director · 16.61K 股 · $5.66M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论